19th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI) 2014

  • Conference Call
  • On behalf of the Orga­niz­ing Com­mit­tee and the Con­gress’ Co-​Chairpersons we cor­dially invite you to join and con­tribute to the suc­cess of the 19th World Con­gress on Con­tro­ver­sies in Obstet­rics, Gyne­col­ogy & Infer­til­ity (COGI) 2014 on Feb­ru­ary 20 – 23, 2014 in Macau, China.

    COGI Macau Con­gress is a con­tin­u­a­tion of the suc­cess of pre­vi­ous edi­tions of the COGI Con­gress held in the Asia Pacific region in Shang­hai, Bei­jing and Hainan which attracted more than 800 par­tic­i­pants in each of the editions.

    COGI Macau is ded­i­cated to the three main stream of our field — Infer­til­ity, Gyne­col­ogy and Peri­na­tol­ogy — and aims to offer pro­fes­sion­als in the field a mul­ti­dis­ci­pli­nary plat­form to learn more about women’s health, gyne­co­log­i­cal oncol­ogy, clin­i­cal research and new discoveries.

    The aim of the COGI Con­gresses in gen­eral is to increase the abil­ity to dis­cuss con­tro­ver­sial top­ics with an empha­sis on clin­i­cal solu­tions in cases where no agreed-​upon answers or con­sen­sus exist. This pro­vides clin­i­cians with an insight and a take-​home mes­sage that ame­lio­rates treat­ment in the most dif­fi­cult sit­u­a­tions and enables the exchange of ideas and infor­ma­tion among mem­bers of var­i­ous countries.

    Con­fer­ence Sessions

    Infertility

    • Opti­miz­ing Art Results: Large dif­fer­ences exist amoung physi­cians and pro­grams in the degree and level of appli­ca­tions of tech­nolo­gies as well as apply­ing the most effec­tive stim­u­la­tion pro­to­col to achieve high suc­cess rate in IVF. The IBSA Edu­ca­tional Work­shop will host dis­tin­guished experts dis­cussing opti­miza­tion of IVF results.
    • In Vitro Mat­u­ra­tion (IVM): Clin­i­cal rel­e­vance of CGH arrays Vs. FISH in embryo screen­ing; IVM: Ovar­ian tis­sue freez­ing and IVM for newly-​diagnosed can­cer patients
    • Luteal Phase Sup­port in Infer­til­ity: the con­tro­versy around luteal phase sup­port – when should we sup­port, with what and for how long – con­tin­ues. While there is no doubt of the need to sup­port the luteal phase with progesto­gens in Infer­til­ity treat­ments, the ques­tion remains: for how long? The role of progesto­gens in recur­rent mis­car­riage is even more com­plex and is based on expert opin­ion rather than on level 1 proofThe con­tro­versy around luteal phase sup­port – when should we sup­port, with what and for how long – con­tin­ues. While there is no doubt of the need to sup­port the luteal phase with progesto­gens in Infer­til­ity treat­ments, the ques­tion remains: for how long? The role of progesto­gens in recur­rent mis­car­riage is even more com­plex and is based on expert opin­ion rather than on level 1 proof.
    • Decreased Ovar­ian Reserve (DOR): DOR is a frus­trat­ing con­di­tion which is asso­ci­ated with lower suc­cess rate and very lit­tle vari­a­tion of the response to treat­ment­DOR is a frus­trat­ing con­di­tion which is asso­ci­ated with lower suc­cess rate and very lit­tle vari­a­tion of the response to treatment
    • Fer­til­ity Preser­va­tion: Cry­op­reser­va­tion and reim­plan­ta­tion of ovar­ian tis­sue: Who are the can­di­dates? Results and techniques
    • Improv­ing Implan­ta­tion Rate: Should we be doing all our embryo trans­fers under ultra­sound guidance?
    • Ovar­ian Stim­u­la­tion (by ISMAAR): It seems odd, but sim­ple ques­tions such as the inten­sity of stim­u­la­tion or no stim­u­la­tion for IVF are still controversial
    • Repeated Implan­ta­tion Fail­ure: Debate: Tthrombophilia/​autoinmune treat­ments improve IVF out­come; How to treat repeated implan­ta­tion fail­ure? Which prog­esta­gen? When and what dose so as to opti­mise luteal sup­port in IVF/​ICSI cycles
    • Treat­ments of PCOS Patients: The con­tro­versy over the man­age­ment of Poly­cys­tic Ovar­ian Syndrome(PCOS) con­tin­ues. The debate here is on the best way in which to achieve a preg­nancy in PCOS patients while min­i­miz­ing risks. Mild stim­u­la­tion IVF,IVM, ovar­ian drilling or GnRH to trig­ger ovu­la­tion: what direc­tion, if any, is prefer­able? Dif­fer­ent points of view – any winner?

    Perinatology

    • Fetal Med­i­cine: Pre­na­tal diag­no­sis on cell-​free DNA, as a non-​invasive method of screen­ing for chro­mo­so­mal ane­u­ploidy is now ready for use in high risk cases mainly. The pos­si­bil­ity to detect point muta­tion expands the indi­ca­tions. Sen­si­tiv­ity, speci­ficity and the nar­row win­dow to its appli­ca­tion remains a concern.
    • Preeclamp­sia – Angio­genic Fac­tors and their Impli­ca­tions in Patient Man­age­ment: A major devel­op­ment was achieved in recent years in iden­ti­fy­ing var­i­ous mark­ers and tools for pre­dict­ing the hyper­ten­sive dis­or­ders weeks before the onset of preeclamp­sia result­ing in sys­temic endothe­lial dys­func­tion, hyper­ten­sion, pro­tein­uria, and the other sys­temic man­i­fes­ta­tions of preeclamp­sia. How­ever, med­i­cine is still short of offer­ing an effec­tive pre­ven­tion plan. The ques­tion is do we lose more by not knowing?
    • Pre­ma­ture Labor: Preterm birth is respon­si­ble to major neona­tal mor­bid­ity and mor­tal­ity; can we pre­dict and pre­vent it?
    • Recur­rent Preg­nancy Loss: LMWH and prog­es­terone to pre­vent recur­rent preg­nancy loss; Preg­nancy Loss: What do we know & what can we do
    • High Risk Deliv­ery: Twins and breeches may be deliv­ered vagi­nally; Debate: Induc­tion of Labor increases cae­sarean sec­tion rate; Debate: Cae­sarean sec­tion for dys­to­cia can be decreased
    • Late Preterm Labors: Late preterm deliv­ery is often asso­ci­ated with mul­ti­ple pregnancies.
    • Dia­betes in Preg­nancy: Should we tighten the glu­cose con­trol in ges­ta­tional dia­betic women? Oral anti-​diabetic drugs, are they really safe? Debate: Should we change the OGTT thresh­olds for diag­nos­ing ges­ta­tional diabetes
    • Cae­sarean Sec­tion (CS): The ever increas­ing CS rate remains a focus of debate, what affects it? Should we strive to decrease?
    • Mul­ti­ple Preg­nan­cies: Mul­ti­ple preg­nancy con­tinue to chal­lenge the obste­tri­cians skills
    • Mon­i­tor­ing: What is the best way of mon­i­tor­ing fetal well­be­ing on the labor ward (fetal blood sam­pling vs. STAN); US in the deliv­ery room; Intra­partum fetal mon­i­tor­ing is a risky busi­ness for both fetus and doc­tor; It is no use to fur­ther improve assess­ment of the early IUGR fetus; pre­ven­tion that is the only issue of impor­tance; “Does Tech­nol­ogy Increase the Rate of Prematurity?”
    • Intrauter­ine Growth Restric­tion (IUGR): IUGR-​Using doppler or not? Fea­si­bil­ity of pre­vent­ing cere­bral palsy with mag­ne­sium sul­fate; Ultra­sonog­ra­phy; Man­age­ment in birth route of IUGR; Office ultra­sound — Used by many under­stood by few

    CME Accreditation

    Accreditation

    Serono Sym­posia Inter­na­tional Foun­da­tion will sub­mit the main con­gress pro­gram of the 19th World Con­gress on Con­tro­ver­sies in Obstet­rics, Gyne­col­ogy & Infer­til­ity (COGI) on Jan­u­ary 23 – 26, 2014 in Macau, China, for accred­i­ta­tion by the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EACCME).

    For the Ital­ian participants

    This pro­gram of the 19th World Con­gress on Con­tro­ver­sies in Obstet­rics, Gyne­col­ogy & Infer­til­ity (COGI) on Jan­u­ary 23 – 26, 2014, Macau, China, will be sub­mit­ted for CME accred­i­ta­tion from the Ital­ian Min­istry of Health.

    The CME accred­i­ta­tion is valid for the main con­gress pro­gram only and does not cover the company-​sponsored symposia.

    ISO 9001 Certification

    Serono Sym­posia Inter­na­tional Foun­da­tion has received the ISO 9001 Cer­ti­fi­ca­tion of Qual­ity Man­age­ment Sys­tems. This Qual­ity cer­ti­fi­ca­tion requires all par­tic­i­pants to fill in a sci­en­tific ques­tion­naire and to eval­u­ate the over­all qual­ity of the event. Ques­tion­naires will be dis­trib­uted onsite dur­ing the congress.

    CME for USA participants

    UEMS/​EACCME CME credit recognition

    The Amer­i­can Med­ical Asso­ci­a­tion (AMA) has an agree­ment of mutual recog­ni­tion of con­tin­u­ing med­ical edu­ca­tion (CME) credit with the Euro­pean Union of Med­ical Spe­cial­ties (UEMS). Under the terms of this agree­ment, the AMA will con­vert CME credit cer­ti­fied by the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EAC­CME), the accred­it­ing arm of the UEMS, to AMA PRA Cat­e­gory 1 Credit™. Physi­cians (MDs, DOs or equiv­a­lent inter­na­tional degree) may have their EAC­CME credit con­verted to AMA PRA Cat­e­gory 1 Credit™ by apply­ing to the AMA.

    starting: ending: 23.02.2014 Location: , Category:

    Timeline

    Conference START 23.02.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address The Venetian Macao Resort Hotel, Estrada da Baia de N. Senhora da Esperanca Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.